A research study focused on the use of magic mushrooms in Canada revealed that nearly 80% of participants support the idea of using psilocybin as a medical treatment for distress. Moreover, approximately two-thirds of these participants also agreed that psilocybin should be legally accessible for those who need it.
Beyond just making psilocybin more accessible, a significant 84.8 percent of participants also believe that the costs of such treatments should be covered by the public health system. A majority of Canadians view psilocybin as a viable treatment option, especially for end-of-life distress.
[toc]
Key Takeaways:
- Citizens of Québec, Ontario, Alberta, and British Columbia view psilocybin as a legitimate medical option for managing existential distress at the end of life.
- Magic mushrooms are seen as a safe treatment option for existential distress.
- Participants in two double-blind trials reported immediate and long-term benefits, with effects extending beyond six months.
Understanding Existential Distress
Existential distress, similar to existential suffering, spiritual distress, and demoralization, arises when individuals confront their own mortality. It can lead to feelings of helplessness, isolation, anxiety, and a loss of significance and purpose. This type of distress is particularly prevalent among patients with life-threatening illnesses, potentially leading to a wish for hastened death or suicidal thoughts.
Individuals grappling with terminal illnesses or major life changes are most likely to experience this type of distress, significantly impacting their mental health and overall quality of life.
Existential therapy aims to address issues such as anxiety, depression, grief, loneliness, despair, confusion about identity, feelings of purposelessness, and existential fear. While it can take multiple sessions and may not work for everyone, it is a commonly sought treatment.
The uncertainty of the effectiveness of such therapy is a primary reason why many individuals seek alternative treatments.
Psilocybin as a Treatment Option: Health Canada’s Perspective
Over the past two decades, early clinical trials have highlighted the possible advantages of psychedelic substances in managing complex mental disorders. Specifically, Psilocybin has been demonstrated to quickly and sustainably ease existential distress in patients approaching the end of their lives.
Recognizing the potential efficacy of these proposed hallucinogenic mushrooms, especially when conventional treatments are inadequate, Health Canada updated the Special Access Program in 2022. This change enables healthcare professionals to request controlled substances for their patients.
Canadian Support for Access to Psilocybin
A study published in the Palliative Care Journal evaluates societal views on psilocybin-assisted therapy for end-of-life care. The data collected in the study includes:
| Methodology | Input from 2,800 Canadians from Québec, Ontario, Alberta, and British Columbia. 19% of them had previously consumed psilocybin (15% in Québec, 26% in British Columbia). |
| Findings | 79.3% view psilocybin-assisted therapy as a legitimate medical option for treating end-of-life existential distress. 63.3% think psilocybin should be integrated into medical treatment. 84.8% back the administration of this therapy by the public health system. 44.2% believe healthcare professionals should dispense the substance without Health Canada’s supervision. |
The findings align with surveys conducted in Canada, England, and Australia. The researchers underscored the distinctiveness of their study, focusing on the use of psychoactive substances to manage existential distress in end-of-life situations.
Why Canadians Support Psilocybin Use
An increasing number of Canadians are supporting the use of psilocybin for treatment, mainly due to discoveries from esteemed research institutions. The perceived safety of psilocybin mushrooms for easing existential distress is another factor. Subjects across various studies have not reported serious adverse health effects, such as multi-organ failure.
| Study | Method | Results |
| Johns Hopkins Study | 51 patients received a high dose of psilocybin and a low dose as an active placebo control | Immediate and enduring The effectiveness of the therapy is primarily due to mystical experiences that foster a sense of unity and deep emotional insights, with benefits lasting up to six months or even longer. |
| New York University Experiment | In this trial, 29 patients were randomly assigned to receive either psilocybin or the active placebo, niacin. | The results of this study echoed those of the Johns Hopkins study. Those participants who received psilocybin reported psychological relief as well as a renewed outlook on life and death. |
| BMC Palliative Care | This study involved interviewing nineteen participants, including 7 doctors, 4 active nurses, 4 chaplains, 3 social workers, and a psychologist. The aim of the study was to gain insight into how palliative care professionals perceive existential distress and their view on psychedelic therapy as a treatment alternative. | The study revealed that, according to palliative care practitioners, psychedelic-assisted therapy (PAT) appears to have potential in alleviating existential distress. |
Patient Experiences
Beyond scientific studies, numerous patient accounts also support the efficacy of psilocybin. These narratives highlight its potential to improve mental wellbeing and overall quality of life.
The Journey of Yokoi
Mio Yokoi, a patient with terminal stage 4 pancreatic cancer, describes a transformative experience during her assisted therapy. She envisioned herself on a raft, surrounded by nature and accompanied by fantastical creatures. This vision led her to deeply realize the interconnection and support within the universe, providing her with immense peace and affirmation.
Despite availing traditional mental health services, Yokoi continued to battle severe anxiety and distress following her diagnosis. Psilocybin therapy enabled her to reconnect with her body and experience a tangible sense of love and support. This has significantly improved her emotional and mental health.
The Story of Chrissy
Chrissy, a woman in her 50s, was battling stage 4 breast cancer that had metastasized to her lungs. She was working full-time as an administrative supervisor in healthcare when the study took place and identified herself as an atheist. She was diagnosed with Generalized Anxiety Disorder during her screening.
Chrissy reported significant reduction in her anxiety, depression, fear of death, hopelessness, and demoralization. When asked if her therapy session had brought any changes in her religious or spiritual beliefs, she replied that the experiences had infused a sense of reality and purpose into her beliefs.
Brenda’s Journey
In her therapy sessions, Brenda confronted the experience of death twice. She came out of these sessions with a fearless view of death, seeing it as an integral part of the cycle of life. She credits the study for initiating her healing process from childhood trauma. The data collected reflects this dramatic change.
It is notable that her anxiety and fear of death lessened, while her sense of spirituality increased.
Availability of Magic Mushroom Products in Canada
Certain restrictions may be placed on the availability of psilocybin capsules and other products intended for managing existential distress and other mental health issues. However, reliable online dispensaries can be a good source for these products when needed.
| Characteristic | Brazilian Psilocybe Cubensis | Cambodian Psilocybe Cubensis | Melmac Psilocybe Cubensis |
| Origin | Native to Brazil and surrounding South American countries. | Discovered in Cambodia, near the Angkor Wat Temple. | Linked to the Penis Envy mushrooms, which became popular in the 1970s. |
| Potency | Moderately potent; suitable for beginners. | Moderately potent; ideal for those starting out. | Extremely potent; advisable for those with intermediate to advanced experience. |
| Effects | Causes a mental high, slight disorientation, enhances color perception, induces euphoria, spiritual experiences, boosts creativity, and improves focus. | Triggers an energizing and enduring high, minor visual alterations, boosts creativity, induces euphoria, a gentle physical high, fractal images, and feelings of joy. | Leads to profound shamanic experiences, vision quests, intense mystical encounters, enhanced creativity, focus, social awareness, and mood boosts. |
Ease End-of-life Discomfort with Psilocybin Products
Existential distress or end-of-life anxiety can put a significant burden on many patients as they approach the end of their lives. Traditional treatments for this distress can often be inadequate, leading to increased support in Canada for easier access to magic mushrooms within public healthcare. This growing public interest could We urge governing bodies to consider the therapeutic use of magic mushrooms. For your psychedelic and mushroom delivery needs, trust Shrooms Edibles Online Canada.
Frequently Asked Questions
What should patients expect during Psilocybin-Assisted Therapy?
Psychedelic-assisted therapy (PAT) experiences can differ greatly from patient to patient. To ensure positive results, patients must follow careful preparation and strict protocols. Before taking the substance, patients must go through comprehensive screening and mental readiness exercises.
- Pre-Session Preparation: Prior to the therapy session, patients undergo detailed assessment. Therapists discuss the patient’s goals and expectations to set clear intentions for the therapy. Therapists also help patients understand what they should expect during the session and the effect of the therapy.
- The Session: The therapeutic session involves administering a controlled dose of the substance in a serene, distraction-free environment to promote relaxation and self-reflection. Therapists provide ongoing support and guidance throughout.
- Post-Session Integration Therapy: This therapy helps patients process and comprehend their experiences. The therapy continues with follow-up sessions that provide ongoing support and counselling to reinforce the insights and changes gained during the therapy.
How does psilocybin affect the brains of distressed patients?
Psilocybin interacts with the brain by binding to serotonin receptors, particularly the 5-HT2A receptor. This interaction can alter perception, mood, and cognition, leading to substantial changes in consciousness, emotional breakthroughs, and new insights.
Is psilocybin therapy available for everyone?
Psilocybin therapy isn’t appropriate for everyone. Patients with specific mental health conditions or existential distress are thoroughly screened to exclude those with a history of psychosis.
Related Articles:
